Stefan Balabanov

4.7k total citations
99 papers, 2.8k citations indexed

About

Stefan Balabanov is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Stefan Balabanov has authored 99 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 35 papers in Hematology and 26 papers in Genetics. Recurrent topics in Stefan Balabanov's work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Telomeres, Telomerase, and Senescence (13 papers). Stefan Balabanov is often cited by papers focused on Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Telomeres, Telomerase, and Senescence (13 papers). Stefan Balabanov collaborates with scholars based in Germany, Switzerland and Italy. Stefan Balabanov's co-authors include Tim H. Brümmendorf, Carsten Bokemeyer, Reinhard Walther, Melanie Braig, Christian Scharf, Ulrike Hartmann, Tim H. Brümmendorf, Uwe Zimmermann, Simone Venz and Artur Gontarewicz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Stefan Balabanov

95 papers receiving 2.7k citations

Peers

Countries citing papers authored by Stefan Balabanov

Since Specialization

Citations

This map shows the geographic impact of Stefan Balabanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Balabanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Balabanov more than expected).

Fields of papers citing papers by Stefan Balabanov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Balabanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Balabanov. The network helps show where Stefan Balabanov may publish in the future.

Co-authorship network of co-authors of Stefan Balabanov

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Balabanov. A scholar is included among the top collaborators of Stefan Balabanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Balabanov. Stefan Balabanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of thrombopoietin receptor agonists versus rituximab in non‐responsive immune thrombocytopenia—A single centre retrospective analysis 2024 ·British Journal of Haematology ·(unknown), (unknown), (unknown), Kevin Hofer, Stefan Balabanov, Markus G. Manz, (unknown)	0
2	Real-time viscoelastic deformability cytometry: High-throughput mechanical phenotyping of liquid and solid biopsies 2024 ·Science Advances ·Mohammad H. Asghari, (unknown), (unknown), Morteza Aramesh, (unknown), Yingchao Meng, (unknown), Monika Colombo, Tobias Weiß, Stefan Balabanov, Stavros Stavrakis, Andrew J. deMello	4
3	Complication rates of peripherally inserted central catheters vs implanted ports in patients receiving systemic anticancer therapy: A retrospective cohort study 2023 ·International Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), Ralph Gnannt, Michael Hofmann, Olivier de Rougemont, (unknown), (unknown), Jan–Dirk Studt, Stefan Balabanov, Andreas Wicki, Anja Lorch, Markus G. Manz, (unknown)	8
4	A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia 2022 ·BMC Cancer ·Nathan Cantoni, Roberto Sommavilla, Patrick Seitz, (unknown), (unknown), Jean‐François Lambert, (unknown), (unknown), Stefan Balabanov	3
5	Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine 2021 ·Cancers ·(unknown), (unknown), (unknown), Michael Daskalakis, (unknown), (unknown), (unknown), Naomi Porret, Ramanjaneyulu Allam, Tata Nageswara Rao, Rudolf Benz, (unknown), (unknown), (unknown), Alicia Rovó, Stefan Balabanov, (unknown), Ulrike Bacher, Nicolas Bonadies	4
6	Disruption of CSF-1R signaling inhibits growth of AML with inv(16) 2021 ·Blood Advances ·Alexander Simonis, Norman F. Russkamp, Jan Mueller, C. Matthias Wilk, Mattheus H. E. Wildschut, Renier Myburgh, (unknown), (unknown), Stefan Balabanov, Peter J.M. Valk, Alexandre Theocharides, Markus G. Manz	7
7	Polyamines Control eIF5A Hypusination, TFEB Translation, and Autophagy to Reverse B Cell Senescence 2019 ·Molecular Cell ·Hanlin Zhang, Ghada Alsaleh, Jack Feltham, Yizhe Sun, Gennaro Napolitano, Thomas Riffelmacher, Philip D. Charles, (unknown), Philip Hublitz, Zhanru Yu, Shabaz Mohammed, Andrea Ballabio, Stefan Balabanov, Jane Mellor, Anna Katharina Simon	222
8	Eculizumab application during pregnancy in a patient with paroxysmal nocturnal hemoglobinuria: A case report with review of the literature 2018 ·Clinical Case Reports ·(unknown), (unknown), Stefan Balabanov, Nina Kimmich	4
9	UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation 2014 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Marlies Sachs, Tobias Meyer, Henning Sievert, Maja T. Lindenmeyer, Thorsten Wiech, Clemens D. Cohen, Stefan Balabanov, Rolf A.K. Stahl, Catherine Meyer‐Schwesinger	13
10	Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection 2014 ·PLoS ONE ·Jasmin Wellbrock, Sara Sheikhzadeh, Leticia Oliveira‐Ferrer, Hauke Stamm, Mathias Hillebrand, Britta Keyser, (unknown), Gabi Vohwinkel, (unknown), Benjamin Otto, Thomas Streichert, Stefan Balabanov, Christian Hagel, Meike Rybczynski, (unknown), Carsten Bokemeyer, Yskert Von Kodolitsch, Walter Fiedler	12
11	Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer 2013 ·Journal of Proteomics ·Sergey A. Dyshlovoy, Simone Venz, Larisa K. Shubina, Sergey N. Fedorov, Reinhard Walther, Christine Jacobsen, Valentin A. Stonik, Carsten Bokemeyer, Stefan Balabanov, Friedemann Honecker	43
12	Marine Alkaloid Monanchocidin: A Proteomic-Based Screening of Protein Targets in Cisplatin-Resistant Tumor Cells 2013 ·Annals of Oncology ·Sergey A. Dyshlovoy, Simone Venz, Alla G. Guzii, (unknown), (unknown), Valentin A. Stonik, Stefan Balabanov, Carsten Bokemeyer, Friedemann Honecker	1
13	Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors 2013 ·PLoS ONE ·Stefan Balabanov, Thomas Wilhelm, Simone Venz, Gunhild Keller, Christian Scharf, Heike Pospisil, Melanie Braig, Christine Barett, Carsten Bokemeyer, Reinhard Walther, Tim H. Brümmendorf, Andreas Schuppert	5
14	Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias 2012 ·Investigational New Drugs ·Patrick Ziegler, (unknown), Thomas Wilhelm, (unknown), Melanie Braig, (unknown), Susanne Ziegler, (unknown), Chris Meier, (unknown), Matthias Rarey, Jens Panse, Joachim Hauber, Stefan Balabanov, Tim H. Brümmendorf	9
15	Ubiquitin C-Terminal Hydrolase-L1 Activity Induces Polyubiquitin Accumulation in Podocytes and Increases Proteinuria in Rat Membranous Nephropathy 2011 ·American Journal Of Pathology ·Catherine Meyer‐Schwesinger, Tobias Meyer, Henning Sievert, Elion Hoxha, Marlies Sachs, (unknown), Silvia Münster, Stefan Balabanov, Lucie Carrier, Udo Helmchen, Friedrich Thaiss, Rolf A.K. Stahl	45
16	Telomere length and telomerase activity in the BCR-ABL-transformed murine Pro-B cell line BaF3 is unaffected by treatment with imatinib 2005 ·Experimental Hematology ·Ulrike Hartmann, Stefan Balabanov, Patrick Ziegler, Jörg Fellenberg, Heiko van der Kuip, Justus Duyster, Hans‐Peter Lipp, Carsten Bokemeyer, Lothar Kanz, Tim H. Brümmendorf	9
17	Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination 2004 ·Cancer Letters ·Uwe Zimmermann, Stefan Balabanov, J. Giebel, Steffen Teller, Heike Junker, Dieter Schmoll, Chris Protzel, Christian Scharf, Britta Kleist, Reinhard Walther	82
18	Human agmatinase is diminished in the clear cell type of renal cell carcinoma 2003 ·International Journal of Cancer ·(unknown), Heike Junker, Stefan Balabanov, Uwe Zimmermann, J. Giebel, Reinhard Walther	54
19	Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors 2003 ·Transfusion ·Stefan Scheding, (unknown), Ulrike Hartmann, (unknown), Stefan Balabanov, Abdulgabar Salama, Lothar Kanz, Tim H. Brümmendorf	7
20	Tumour‐related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two‐dimensional gel electrophoresis 2001 ·European Journal of Biochemistry ·Stefan Balabanov, Uwe Zimmermann, Chris Protzel, Christian Scharf, (unknown), Reinhard Walther	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact